Hoopes Vision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

“As a clinical study site, we at Hoopes Vision are able to give our patients access to the most cutting-edge treatment options for cataracts,” Dr. Hoopes, Jr. said. “Today, we are excited to begin enrolling patients in the IC-8 lens clinical study. This study will focus on how small aperture technology extends the range of vision compared to a traditional single-focus monofocal IOL. For the patient, this may mean better near, intermediate and far vision.”

By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops, leading to blurry vision and eventually vision loss. The only solution to a cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single-focus) lens, which allows the patient to have excellent far vision; however, patients remain dependent on glasses for near and intermediate vision.

Dr. Phillip C. Hoopes, Jr. and Dr. Majid Moshirfar are part of a select group of clinical investigators across the United States for the IC-8 lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.

Hoopes Vision is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:

• At least 22 years of age.
• Have cataracts in both eyes.
• Are available, willing and able to participate in examinations and all follow-up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Trey in the Research Department at Hoopes Vision at (801) 988-7342 or at research@hoopesvision.com.

ABOUT US

Hoopes Vision is the premier LASIK, PRK, and cataract surgery facility in Utah. Within their state-of-the-art facility, located in Draper, Utah, clinical research occupies a dedicated wing where clinical trials for new devices, procedures, drugs, and other technologies are conducted. For more information go to www.hoopesvision.com or call 801-988-7342.

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of vision. The IC-8 lens received its CE mark in 2014 and is available in select markets across Europe and Asia. Founded in 2001, AcuFocus is based in Irvine, Calif. For additional information about the IC-8 intraocular lens, visit www.ic8lensclinicalstudy.com or https://www.facebook.com/ic8lensclinicalstudy.

Caution: Investigational Device. Limited by Federal (or United States) law to investigational use.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190221005269/en/